| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |